Summary of Research: Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan

By sjmartinez • September 22, 2024

Tangri N, Rastogi A, Sofue T. Summary of Research: Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan. Adv Ther. 2024 Sep 19. doi: 10.1007/s12325-024-02961-3. Epub ahead of print. PMID: 39298075.

Tags: albuminuria, Chronic kidney disease, dapagliflozin, effectiveness, Epidemiology, Nephrology, Publications, SGLT-2i, Urinary albumin-to-creatinine ratio

CryoEM and computational modeling structural insights into the pH regulator NBCn1

Wang W, R Zhekova H, Tsirulnikov K, Dwadasi BS, Aparicio EG, Azimov R, Abuladze N, Kao L, Acuna D, Tieleman DP, Zhou ZH, Pushkin A,[...]

Dosing, treatment patterns and safety of finerenone use in routine care: an interim analysis of the prospective, real-world and observational FINE-REAL study

Wheeler DC, Pantalone KM, Guo L, Desai NR, Correa-Rotter R, Nicholas SB, Kim NH, Zheng Z, Scott C, Horvat-Broecker A, Merz M, Wanner C, Navaneethan[...]

Enhancing accuracy and adherence in blood pressure monitoring in living kidney donation: implementing technologies to overcome challenges

Tantisattamo E, Rattanasompattikul M, Traitanon O, Eguchi N, Ichii H, Kantachuvesiri S, Kalantar-Zadeh K. Enhancing accuracy and adherence in blood pressure monitoring in living kidney[...]